141 related articles for article (PubMed ID: 3941271)
1. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
Patek PQ; Lin Y; Collins JL; Cohn M
J Immunol; 1986 Jan; 136(2):741-5. PubMed ID: 3941271
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
Patek PQ; Lin Y
J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
[TBL] [Abstract][Full Text] [Related]
3. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.
Halachmi E; Witz IP
Cancer Res; 1989 May; 49(9):2383-9. PubMed ID: 2539901
[TBL] [Abstract][Full Text] [Related]
4. An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis.
Lin Y; Collins JL; Patek PQ; Cohn M
J Immunol; 1983 Sep; 131(3):1154-9. PubMed ID: 6604090
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
[TBL] [Abstract][Full Text] [Related]
6. Analysis of immune surveillance of sequentially derived cell lines that differ in their tumorigenic potential.
Lin Y; Patek PQ; Collins JL; Cohn M
J Natl Cancer Inst; 1985 May; 74(5):1025-30. PubMed ID: 3873568
[TBL] [Abstract][Full Text] [Related]
7. Tumor growth in vivo selects for resistance to tumor necrosis factor.
Lattime EC; Stutman O
J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
[TBL] [Abstract][Full Text] [Related]
8. Differential tumorigenicity of growth factor-dependent versus -independent CCL39 lung fibroblast lines in nude mice.
Renwick DE; Franchi AJ; Pouysségur JM; Lagarde AE
J Natl Cancer Inst; 1986 Jul; 77(1):105-14. PubMed ID: 3459908
[TBL] [Abstract][Full Text] [Related]
9. Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms.
Patek PQ; Lin Y; Collins JL
J Immunol; 1987 Mar; 138(5):1641-6. PubMed ID: 3805728
[TBL] [Abstract][Full Text] [Related]
10. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
Pohajdak B; Wright JA; Greenberg AJ
J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
[TBL] [Abstract][Full Text] [Related]
11. A murine model for B-cell lymphomagenesis in immunocompromised hosts: natural killer cells are an important component of host resistance to premalignant B-cell lines.
Felsher DW; Rhim SH; Braun J
Cancer Res; 1990 Nov; 50(21):7050-6. PubMed ID: 2208172
[TBL] [Abstract][Full Text] [Related]
12. [Immunological and morphological properties of fibroblasts transformed in vitro. II. The change in the susceptibility of FC3H3 cells to lymphocytes--natural killers and macrophages during their selection for malignancy].
Lavrovskiĭ VA; Iurchenko IuA; Viksler VKh
Tsitologiia; 1984 Oct; 26(10):1181-5. PubMed ID: 6515718
[TBL] [Abstract][Full Text] [Related]
13. Some immunological properties of high and low tumorigenic cellular variants of c-H-ras transformed 3T3 cells.
Gonen B; Ran M; Wreschner D; Cahalon L; Anavi R; Shlomo Y; Witz IP
Nat Immun Cell Growth Regul; 1988; 7(3):144-54. PubMed ID: 3050475
[TBL] [Abstract][Full Text] [Related]
14. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
15. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
Schiller JH; Bittner G
Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
[TBL] [Abstract][Full Text] [Related]
16. [Immunological and morphological properties of in vitro transformed fibroblasts. III. Recognition by macrophages and activated lymphocytes of mouse and rat cells of various degrees of tumorigenicity].
Lavrovskiĭ VA; Iurchenko IuA; Guvakova MA
Tsitologiia; 1987 May; 29(5):589-95. PubMed ID: 3617224
[TBL] [Abstract][Full Text] [Related]
17. Evidence that cytotoxic T cells and natural cytotoxic cells use different lytic mechanisms to lyse the same targets.
Patek PQ; Collins JL; Cohn M
Eur J Immunol; 1983 May; 13(5):433-6. PubMed ID: 6189729
[TBL] [Abstract][Full Text] [Related]
18. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
Zöller M; Matzku S
Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
[TBL] [Abstract][Full Text] [Related]
19. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]